Throughout the history of the Program Project Grant, Core C has provided centralized, standardized research services that have enabled Program investigators to engage in cutting edge research. Core C faculty and staff have been dedicated to providing a coordinated and collaborative resource to support Program investigators and their individual projects by providing precise and consistent results using the most up-to-date technology and services. Core C facilities and services are available to all members of the Program Project Grant and continue to be critical for the success of all projects in the current proposal. The University of Mississippi Medical Center continues to support Core C by providing partial salary funding for key personnel and essential equipment needed for the high volume of assay samples. All personnel in Core C are readily available to provide technical support as well as assistance with the operation of any equipment within the core. In addition, all personnel in Core C are committed to serving as a resource for the development of new assays and methodologies. Technologies and services provided by Core C include radioimmunoassay and HPLC, molecular, cellular, and biochemical, histology and immunohistochemistry, and a transgenic facility in addition to the maintenance of specialized instrumentation and equipment necessary for many molecular/biochemical and histological applications. During the past 5 years several Program investigators have required development of additional RIA, HPLC, and molecular analyses, histological services, and transgenic mice. Most of the equipment for these new studies has been purchased by the University of Mississippi Medical Center (UMMC). This investment by the Medical Center has made it possible to establish specialized core facilities including Molecular/Biochemical and Histological laboratories with expanded capabilities. In addition, a transgenic facility has been established for the development of transgenic and gene targeted mice for Program investigators. Major equipment critical to the development of the transgenic facility was also purchased by UMMC. Development of specialized core facilities within Core C consolidates many methods and procedures utilized by various Program investigators in their respective laboratories providing shared resources for all Program investigators. Core C also provides the Program Project's Safety Officer (Dr. Terry Dwyer) and a Safety Technician in the areas of Radiation Safety, Infection Control (blood-borne pathogens), and Hazardous Chemical Safety. Core C advises and assists investigators and their technicians in proper safety procedures, monitors compliance with local and federal policies and regulations, and coordinates disposal of radioactive, infectious, and other hazardous or medical waste.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051971-19
Application #
8374567
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2011-12-01
Budget End
2012-11-30
Support Year
19
Fiscal Year
2012
Total Cost
$286,379
Indirect Cost
$92,896
Name
University of Mississippi Medical Center
Department
Type
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Jung, Mira; Ma, Yonggang; Iyer, Rugmani Padmanabhan et al. (2017) IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol 112:33
Ma, Yonggang; Iyer, Rugmani Padmanabhan; Jung, Mira et al. (2017) Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps. Trends Pharmacol Sci 38:448-458
Feng, Ruiqi; Liu, Jia; Wang, Zhenhua et al. (2017) The structure-activity relationship of ginsenosides on hypoxia-reoxygenation induced apoptosis of cardiomyocytes. Biochem Biophys Res Commun 494:556-568
Muntner, Paul; Abdalla, Marwah; Correa, Adolfo et al. (2017) Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study). Hypertension 69:761-769
Chade, Alejandro R (2017) Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury. Hypertension 69:551-563
Drummond, Heather A; Xiang, Lusha; Chade, Alejandro R et al. (2017) Enhanced maximal exercise capacity, vasodilation to electrical muscle contraction, and hind limb vascular density in ASIC1a null mice. Physiol Rep 5:
Faulkner, Jessica L; Amaral, Lorena M; Cornelius, Denise C et al. (2017) Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension. Am J Physiol Regul Integr Comp Physiol 312:R125-R131
Blair, Evan T; Clemmer, John S; Harkey, H Louis et al. (2017) Physiologic Mechanisms of Water and Electrolyte Disturbances After Transsphenoidal Pituitary Surgery. World Neurosurg 107:429-436
Bakrania, Bhavisha A; Spradley, Frank T; Satchell, Simon C et al. (2017) Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells. Am J Physiol Regul Integr Comp Physiol :
Taylor, Erin B; Ryan, Michael J (2017) Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease. J Am Heart Assoc 6:

Showing the most recent 10 out of 723 publications